161 related articles for article (PubMed ID: 33046131)
21. [Angioimmunoblastic T-cell lymphoma occurring four months after autologous peripheral blood stem cell transplantation with high-dose chemotherapy for follicular lymphoma].
Miyazaki K; Masuya M; Yamaguchi M; Isaka S; Nakase K; Kobayashi T; Nakamura S; Shiku H
Rinsho Ketsueki; 2005 Sep; 46(9):1065-70. PubMed ID: 16440766
[TBL] [Abstract][Full Text] [Related]
22. Angioimmunoblastic T-cell lymphoma and membranous nephropathy: a still unreported association.
Togashi M; Wakui H; Kodama K; Kameoka Y; Komatsuda A; Nimura T; Ichinohasama R; Sawada K
Clin Exp Nephrol; 2010 Jun; 14(3):288-93. PubMed ID: 20177729
[TBL] [Abstract][Full Text] [Related]
23. Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial.
Poeschel V; Held G; Ziepert M; Witzens-Harig M; Holte H; Thurner L; Borchmann P; Viardot A; Soekler M; Keller U; Schmidt C; Truemper L; Mahlberg R; Marks R; Hoeffkes HG; Metzner B; Dierlamm J; Frickhofen N; Haenel M; Neubauer A; Kneba M; Merli F; Tucci A; de Nully Brown P; Federico M; Lengfelder E; di Rocco A; Trappe R; Rosenwald A; Berdel C; Maisenhoelder M; Shpilberg O; Amam J; Christofyllakis K; Hartmann F; Murawski N; Stilgenbauer S; Nickelsen M; Wulf G; Glass B; Schmitz N; Altmann B; Loeffler M; Pfreundschuh M; ;
Lancet; 2019 Dec; 394(10216):2271-2281. PubMed ID: 31868632
[TBL] [Abstract][Full Text] [Related]
24. Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG).
Lenz G; Dreyling M; Hoster E; Wörmann B; Dührsen U; Metzner B; Eimermacher H; Neubauer A; Wandt H; Steinhauer H; Martin S; Heidemann E; Aldaoud A; Parwaresch R; Hasford J; Unterhalt M; Hiddemann W
J Clin Oncol; 2005 Mar; 23(9):1984-92. PubMed ID: 15668467
[TBL] [Abstract][Full Text] [Related]
25. Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group.
Schmitz N; Trümper L; Ziepert M; Nickelsen M; Ho AD; Metzner B; Peter N; Loeffler M; Rosenwald A; Pfreundschuh M
Blood; 2010 Nov; 116(18):3418-25. PubMed ID: 20660290
[TBL] [Abstract][Full Text] [Related]
26. Ankylosing spondylitis combined with angioimmunoblastic T cell lymphoma.
Xu L
BMJ Case Rep; 2011 Sep; 2011():. PubMed ID: 22679193
[TBL] [Abstract][Full Text] [Related]
27. Emergence of anti-mitochondrial M2 antibody in patient with angioimmunoblastic T-cell lymphoma.
Wakabayashi SI; Kimura T; Tanaka N; Joshita S; Kawata K; Umemura T; Hiroshima Y; Mori H; Kobayashi H; Wada S; Tanaka E
Clin J Gastroenterol; 2018 Aug; 11(4):302-308. PubMed ID: 29428971
[TBL] [Abstract][Full Text] [Related]
28. Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma by combined methotrexate and prednisone.
Gerlando Q; Barbera V; Ammatuna E; Franco V; Florena AM; Mariani G
Haematologica; 2000 Aug; 85(8):880-1. PubMed ID: 10942945
[No Abstract] [Full Text] [Related]
29. Cardiovascular adverse events in patients with non-Hodgkin lymphoma treated with first-line cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP with rituximab (R-CHOP): a systematic review and meta-analysis.
Linschoten M; Kamphuis JAM; van Rhenen A; Bosman LP; Cramer MJ; Doevendans PA; Teske AJ; Asselbergs FW
Lancet Haematol; 2020 Apr; 7(4):e295-e308. PubMed ID: 32135128
[TBL] [Abstract][Full Text] [Related]
30. T-cell lymphomas, a challenging disease: types, treatments, and future.
Ma H; Abdul-Hay M
Int J Clin Oncol; 2017 Feb; 22(1):18-51. PubMed ID: 27743148
[TBL] [Abstract][Full Text] [Related]
31. SIE-SIES-GITMO guidelines for the management of adult peripheral T- and NK-cell lymphomas, excluding mature T-cell leukaemias.
Corradini P; Marchetti M; Barosi G; Billio A; Gallamini A; Pileri S; Pimpinelli N; Rossi G; Zinzani PL; Tura S
Ann Oncol; 2014 Dec; 25(12):2339-2350. PubMed ID: 24723488
[TBL] [Abstract][Full Text] [Related]
32. Diffuse large B-cell lymphoma in patient after treatment of angioimmunoblastic T-cell lymphoma.
Skugor ND; Perić Z; Vrhovac R; Radić-Kristo D; Kardum-Skelin I; Jaksić B
Coll Antropol; 2010 Mar; 34(1):241-5. PubMed ID: 20432757
[TBL] [Abstract][Full Text] [Related]
33. Primary colorectal T-cell lymphoma.
Okada M; Maeda K; Suzumiya J; Hagimoto T; Wakamatsu S; Ohshima K; Kanda M; Sonoda T; Sakamoto A; Tamura K
J Gastroenterol; 2003; 38(4):376-84. PubMed ID: 12743779
[TBL] [Abstract][Full Text] [Related]
34. Primary cerebral angioimmunoblastic T-cell lymphoma.
Lachenal F; Berger F; Cimarelli S; Formaglio M; Ghesquières H
J Clin Oncol; 2013 Feb; 31(5):e64-8. PubMed ID: 23295811
[No Abstract] [Full Text] [Related]
35. Cyclosporine treatment of angioimmunoblastic T-cell lymphoma relapsed after an autologous hematopoietic stem cell transplant.
Wang X; Zhang D; Wang L; Huang J; Yang Z; Wang J; Chen J; Liu L
Exp Clin Transplant; 2015 Apr; 13(2):203-5. PubMed ID: 24918480
[TBL] [Abstract][Full Text] [Related]
36. Fatal septicemic shock associated with Strongyloides stercoralis infection in a patient with angioimmunoblastic T-cell lymphoma: a case report and literature review.
Abdelrahman MZ; Zeehaida M; Rahmah N; Norsyahida A; Madihah B; Azlan H; Nazlee WZ
Parasitol Int; 2012 Sep; 61(3):508-11. PubMed ID: 22575692
[TBL] [Abstract][Full Text] [Related]
37. Angioimmunoblastic T-Cell Lymphoma.
Broccoli A; Zinzani PL
Hematol Oncol Clin North Am; 2017 Apr; 31(2):223-238. PubMed ID: 28340875
[TBL] [Abstract][Full Text] [Related]
38. B-immunoblastic lymphoma arising in angioimmunoblastic lymphadenopathy.
Pirker R; Schwarzmeier JD; Radaszkiewicz T; Lenzhofer R; Konrad K; Bettelheim P; Bauer K; Prischl F
Acta Haematol; 1986; 75(2):105-9. PubMed ID: 3090816
[TBL] [Abstract][Full Text] [Related]
39. Combination of romidepsin with cyclophosphamide, doxorubicin, vincristine, and prednisone in previously untreated patients with peripheral T-cell lymphoma: a non-randomised, phase 1b/2 study.
Dupuis J; Morschhauser F; Ghesquières H; Tilly H; Casasnovas O; Thieblemont C; Ribrag V; Bossard C; Le Bras F; Bachy E; Hivert B; Nicolas-Virelizier E; Jardin F; Bastie JN; Amorim S; Lazarovici J; Martin A; Coiffier B
Lancet Haematol; 2015 Apr; 2(4):e160-5. PubMed ID: 26687958
[TBL] [Abstract][Full Text] [Related]
40. Leukaemic presentation of angioimmunoblastic T-cell lymphoma.
Lin KW; Lee YS; Phipps C
Br J Haematol; 2014 Sep; 166(6):808. PubMed ID: 24974735
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
